Sentence examples for unfavourable cases from inspiring English sources

The observed polymerization reaction which in unfavourable cases consumes almost all converted toluene is contrary to predictions and model calculations which are based on voltametric data.

Indeed, we observed such unfavourable cases when for example T = 3 and D = 20.

In this validation set (Table 2B), patients classified as 'Favourable' were slightly younger (P=0.02) and had a better OS than 'Unfavourable' cases with 5-year OS of 57 vs 27%, respectively (P=1.56E-05; Figure 4A).

Indeed, OS was higher in the 'Favourable' cases than in the 'Unfavourable' cases, both in tumours without residual disease (5-year OS: 73 vs 30% P=1.3E-03 P=1.3E-03umours with residuanddinease aftumoursgery (5-year OS: 43 vs 21%, P=1.9E-03; Figure 4B).

In the most unfavourable case, in which data were interpreted unfavourably in five instances to create a very highly unlikely scenario, the mobile screening unit had an incremental cost effectiveness ratio of about £26 000 (table 4).

Iran's existing nuclear weapons capabilities are nil, but all too often the most unfavourable case assumptions about the country's nuclear ambitions are played up, particularly in America and Israel.

Indeed these reached 9.0% in the most unfavourable case, that is, breed A, but only 6.7% in the heaviest breed P.

This sample size also ensures correct estimation of the populational prevalence of asymptomatic AAI in our medium with a precision of 2%, accepting an alpha risk of 0.05 in the most unfavourable case of having to detect a prevalence of 50%.

These events outside of medical research cannot be ignored, as there is the potential for these to have an effect on the medical research context, which in the case of an unfavourable event could undermine the public trust and support that is necessary for medical research to continue and to thrive.

Using clinical stage, histological grade and presenting PSA to define prognostic groups showed 5-year actuarial PSA control rates in 77 vs 90% (P=0.05), 50 vs 70% (P=0.001) and 21 vs 47% (P=0.002) of favourable, intermediate and unfavourable risk cases treated to lower or higher doses, respectively.

Differences in the expression pattern of the receptors or their downstream signalling components could in part explain the differences in favourable (in the case of TrkA) or unfavourable (in the case of TrkB) tumors.